azacitidine has been researched along with Down Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iijima, K; Ito, E; Mori, T; Nagano, C; Nishimura, N; Takafuji, S; Terui, K; Toki, T; Uemura, S | 1 |
| Croy, BA; Hatta, K; Jenkins, EC; Kerkel, K; Kratz, A; Mayeux, RP; Minden, M; Murty, V; Pang, D; Salas, M; Schork, NJ; Schupf, N; Silverman, W; Torkamani, A; Tycko, B; Zigman, WB | 1 |
| Abella, E; Alvarado, CS; Chauvenet, A; Dubowy, R; Harris, M; Inoue, S; Krischer, JP; Ravindranath, Y; Ritchey, AK; Wiley, J | 1 |
3 other study(ies) available for azacitidine and Down Syndrome
| Article | Year |
|---|---|
Effective response to azacitidine in a child with a second relapse of myeloid leukemia associated with Down syndrome after bone marrow transplantation.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow Transplantation; Child, Preschool; Down Syndrome; Female; Humans; Leukemia, Myeloid; Neoplasm Recurrence, Local | 2018 |
Altered DNA methylation in leukocytes with trisomy 21.
Topics: Adult; Aging; Azacitidine; Child; Child, Preschool; DNA Methylation; Down Syndrome; Gene Expression Profiling; Gene Expression Regulation; Humans; Infant; Jurkat Cells; Leukocyte Count; Leukocytes; Lymphocytes; Nerve Tissue Proteins; Nod2 Signaling Adaptor Protein; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; RNA, Messenger; Sequence Analysis, DNA; Sulfites | 2010 |
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azacitidine; Child; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Thioguanine; Vincristine | 1992 |